Dr. Vogelstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1650 Orleans St
Crb1, Room 589
Baltimore, MD 21287Phone+1 410-955-8878
Education & Training
- Johns Hopkins UniversityResidency, Pediatrics, 1974 - 1976
- Johns Hopkins University School of MedicineClass of 1974
Certifications & Licensure
- MD State Medical License 1974 - 2023
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2001
- Elected Member The American Society for Clinical Investigation, 1986
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Join now to see all
Publications & Presentations
PubMed
- A Blood-based Assay for Detection of Patients with Advanced Adenomas.Kamel Lahouel, Christopher Douville, Brenda Diergaarde, Joshua D Cohen, Haley Grant
Cancer Research Communications. 2025-03-18 - Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.Jeanne Tie, Yuxuan Wang, Serigne N Lo, Kamel Lahouel, Joshua D Cohen
Nature Medicine. 2025-03-07 - Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape.Ashley L Cook, Surojit Sur, Laura Dobbyn, Evangeline Watson, Joshua D Cohen
Elife. 2025-02-17
Journal Articles
- Original Contribution Targeted Sequencing of Plasmacytoid Urothelial Carcinoma Reveals Frequent TERT Promoter Mutations☆Morgan Cowan, Bert Vogelstein, Trinity J Bivalacqua, Gunes Guner, ScienceDirect
- Minimal Functional Driver Gene Heterogeneity Among Untreated MetastasesMarc A Attiyeh, Bert Vogelstein, Zachary A Kohutek, Science Magazine
- Reconstructing Metastatic Seeding Patterns of Human CancersBert Vogelstein, MD, Nature
Press Mentions
- Intra-ImmuSG Focuses on Intracellular Targets for Cancer ImmunotherapyFebruary 10th, 2025
- Two Johns Hopkins Medicine Scientists Win Harvey PrizeDecember 9th, 2024
- FDA Approves Drug That Targets Brain Cancer Gene Mutation That Could Delay Need for Radiation and ChemotherapyAugust 17th, 2024
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/bert-vogelstein
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: